| 今开：34.51 | 昨收：35.54 |
| 最高：35.09 | 最低：32.0288 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.5199244E8 |
股界一粒沙01-27 02:24
$Corbus制药控股(CRBP)$ $新诺威(SZ300765)$ $石药集团(01093)$
Corbus数据公布后股价暴涨，截止发帖时间已经上涨3倍多。
近日，石药集团/Corbus在2024年(ASCO-GU2024)上，公布了靶向nectin-4抗体药物偶联物（ADC）SYS6002的I期剂量递增数据。
具体数据可以查询Corbus发布的公告...查看全文
Corbus(CRBP)02-05 21:15
$Corbus制药控股(CRBP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0000950170-24-011013 Act: 34 Size: 29 MB 网页链接查看全文
Corbus(CRBP)02-06 05:55
$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000374 Act: 34 Size: 110 KB 网页链接查看全文
Corbus(CRBP)01-27 05:35
$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-001240 Act: 34 Size: 84 KB 网页链接查看全文
Corbus(CRBP)01-31 05:25
$Corbus制药控股(CRBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000929638-24-000303 Size: 7 KB 网页链接查看全文
Corbus(CRBP)02-29 06:05
$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000053 Act: 34 Size: 81 KB 网页链接查看全文
Corbus(CRBP)03-01 06:15
$Corbus制药控股(CRBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-24-004119 Size: 6 KB 网页链接查看全文
Corbus(CRBP)04-03 04:35
$Corbus(CRBP)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-040242 Act: 34 Size: 2 MB 网页链接查看全文
Corbus(CRBP)03-21 05:15
$Corbus制药控股(CRBP)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-034271 Act: 34 Size: 148 KB 网页链接查看全文
美股律师郝俊波2019-03-01 13:25
$Corbus制药控股(CRBP)$ Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)因被指控犯有证券欺诈者有牵连而且研发的新药lenabasum试验失败等重大不利消息而股价下跌。如果您投资该证券受损，请点击我们的雪球网相关集体诉讼专题页：网页链接查看全文
usbiostock2018-06-29 10:08
回复@滑板鞋2018: 除了GLPG和VRTX，做囊性纤维化（CF）的还有$ProQR Therapeutics N.V. - Ordinary Shares(PRQR)$ $Proteostasis Therapeutics, Inc.(PTI)$ $Corbus Pharmaceuticals Holdings, Inc. (CRBP)$ 还有一家没上市的Celtaxsys也做到临床2b期了，今年夏天会公布数据。这个病不好做，之前已...查看全文
木月皿2015-09-19 10:55
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 10月8-10日 North American Cystic Fibrosis Conference，Resunab抗炎数据（Poster已出），临床前。近期多笔内部买入。查看全文
木月皿2015-06-13 09:54
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 1. 6月9日和12日已有3个内部人士购买；2 3项临床2期试验；3. 孤儿药地位；4.CFF和NIH资助；5. Vertex/Parion合作。查看全文
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005284 Size: 7 KB 网页链接
$Corbus(CRBP)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0000950170-24-043417 Act: 34 Size: 650 KB 网页链接
$Corbus(CRBP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-043418 Act: 34 Size: 42 KB 网页链接
$Corbus(CRBP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-040247 Act: 34 Size: 171 KB 网页链接
$Corbus(CRBP)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-040250 Act: 34 Size: 2 MB 网页链接
$Corbus(CRBP)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-040242 Act: 34 Size: 2 MB 网页链接
$Corbus(CRBP)$ PRE 14A Other preliminary proxy statements Accession Number: 0000950170-24-035466 Act: 34 Size: 1 MB 网页链接
$Corbus(CRBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000696 Act: 33 Size: 1 KB 网页链接
$Corbus制药控股(CRBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0000950170-24-034262 Act: 33 Size: 245 KB 网页链接
$Corbus制药控股(CRBP)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034266 Act: 34 Size: 3 MB 网页链接